Literature DB >> 32130796

Improved oxygen systems at hospitals in three Nigerian states: An implementation research study.

Chizoba Fashanu1, Tinsae Mekonnen2, Joseph Amedu3,4, Ngozi Onwundiwe3,4, Adebimpe Adebiyi3,4, Oluseyi Omokere3,4, Tayo Olaleye1, Martha Gartley2, Seyi Gansallo1, Funsho Lewu1, Abraham Okita1, Mahmud Musa1, Ashiru Abubakar1, Tolulope Ojo1, Amina Ja'afar1, Adebayo Abdulateef Ekundayo1, Mohammed Lawal Abubakar1, Kate Schroder2, Audrey Battu2, Owens Wiwa1, Jason Houdek2, Felix Lam2.   

Abstract

INTRODUCTION: Hypoxemia is a life-threatening condition and is commonly seen in children with severe pneumonia. A government-led, NGO-supported, multifaceted oxygen improvement program was implemented to increase access to oxygen therapy in 29 hospitals in Kaduna, Kano, and Niger states. The program installed pulse oximeters and oxygen concentrators, trained health care workers, and biomedical engineers (BMEs), and provided regular feedback to health care staff through quality improvement teams.
OBJECTIVE: The aim of this study is to evaluate whether the program increased screening for hypoxemia with pulse oximetry and prescription of oxygen for patients with hypoxemia.
METHODOLOGY: The study is an uncontrolled before-after interventional study implemented at the hospital level. Medical charts of patients under 5 admitted for pneumonia between January 2017 and August 2018 were reviewed and information on patient care was extracted using a standardized form. The preintervention period of this study was defined as 1 January to 31 October 2017 and the postintervention period as 1 February to 31 August 2018. The primary outcomes of the study were whether blood-oxygen saturation measurements (SpO2 ) were documented and whether children with hypoxemia were prescribed oxygen.
RESULTS: A total of 3418 patient charts were reviewed (1601 during the preintervention period and 1817 during the postintervention period). There was a significant increase in the proportion of patients with SpO2 measurements after the interventions were conducted (adjusted odds ratio [aOR] 5.0; 4.3-5.7, P < .001). Before the interventions, only 13.7% (95% confidence interval [CI]: 12.2-15.3) of patients had SpO2 measurements and after the interventions, 82.4% (95% CI: 80.7-84.1) had SpO2 measurements. Oxygen administration for patients with clinical signs of hypoxemia also increased significantly (aOR 5.0; 4.2-5.9, P < .001)-from 22.8% (95% CI: 18.8-27.2) to 77.9% (95% CI: 73.9-81.5).
CONCLUSION: Increasing pulse oximetry and oxygen therapy access and utilization in a low-resourced environment is achievable through a multifaceted program focused on strengthening government-owned systems.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  developing countries; hypoxia; pneumonia

Year:  2020        PMID: 32130796     DOI: 10.1002/ppul.24694

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  3 in total

1.  Pulse oximetry and oxygen services for the care of children with pneumonia attending frontline health facilities in Lagos, Nigeria (INSPIRING-Lagos): study protocol for a mixed-methods evaluation.

Authors:  Hamish R Graham; Omotayo E Olojede; Ayobami Adebayo A Bakare; Eric D McCollum; Agnese Iuliano; Adamu Isah; Adams Osebi; Ibrahim Seriki; Tahlil Ahmed; Samy Ahmar; Christine Cassar; Paula Valentine; Temitayo Folorunso Olowookere; Matt MacCalla; Obioma Uchendu; Rochelle Ann Burgess; Timothy Colbourn; Carina King; Adegoke G Falade
Journal:  BMJ Open       Date:  2022-05-02       Impact factor: 3.006

2.  Oxygen systems strengthening as an intervention to prevent childhood deaths due to pneumonia in low-resource settings: systematic review, meta-analysis and cost-effectiveness.

Authors:  Felix Lam; Angela Stegmuller; Victoria B Chou; Hamish R Graham
Journal:  BMJ Glob Health       Date:  2021-12

3.  Oxygen therapy for children: A key tool in reducing deaths from pneumonia.

Authors:  Hamish Graham; Ayobami A Bakare; Chizoba Fashanu; Owens Wiwa; Trevor Duke; Adegoke G Falade
Journal:  Pediatr Pulmonol       Date:  2020-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.